SEC Form 4 · accession 0001209191-17-035497
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Simard
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
May 24, 2017
Accepted (ET)
May 25, 2017 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 24, 2017 | M | 240,000 | $0.9317 | A | 6,393,267 | D | |
| Common Stock | May 24, 2017 | F | 116,207 | $8.17 | D | 6,277,060 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $0.9317 | May 24, 2017 | M | 240,000 | D | Jun 15, 2008 | Jun 15, 2017 | Common Stock | 240,000 | 0 | D |
Explanation of responses
- F1Options granted on June 15, 2007 with a strike price of $1.25 CAD, which was converted to $0.9317 USD using an exchange rate of 0.7454.
- F2Due to the options expiring on June 15, 2017, Mr. Simard agreed to exercise these options through the "net exercise" method on May 24, 2017. Mr. Simard received 123,793 shares of common stock on a net exercise to purchase 240,000 shares of common stock. Mr. Simard forfeited 116,207 shares of common stock underlying the option in payment of the exercise price and associated taxes, using the closing stock price on May 24, 2017 of $8.17.